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OBJECTIVES The goal of this study was to assess the safety and efficacy of femoral artery pseudoaneurysm
(FAP) closure by collagen injection.
BACKGROUND The FAP is an infrequent but troublesome complication after percutaneous transfemoral
catheter procedures. If ultrasound-guided compression repair (UGCR) fails, vascular surgery
is indicated. We have developed a less invasive method to close FAPs percutaneously by
injecting collagen and, thus, inducing clotting within the aneurysm.
METHODS Via a 9F needle or 11F sheath, a biodegradable adhesive bovine collagen is injected
percutaneously into the FAP, guided by angiography from the contralateral site.
RESULTS From 1993 to 2000, compression and UGCR had failed to obliterate 110 FAPs. These
patients have been treated by collagen injection. Mean age of the patients was 65.6  10.2
years (range: 32 to 85 years), and 50% were women. Immediate closure of the FAP was
achieved in 107/110 patients (97.3%) without any complication or adverse effect. In one
patient the collagen could not be applied due to unfavorable anatomy. One patient needed a
second session of collagen injection. In one patient too much collagen was inserted, which
resulted in external compression of the artery, and surgical intervention was required. The
overall success rate was 108/110 (98%, 95% confidence interval: 93.5% to 99.8%). Among the
patients with successful procedures, there were no recurrences during six months follow-up.
CONCLUSIONS The percutaneous treatment of iatrogenic FAP, by injection with collagen, is an effective and
safe strategy. This method provides an excellent therapeutic alternative to the traditional
surgical management. (J Am Coll Cardiol 2002;39:1297–304) © 2002 by the American
College of Cardiology Foundation
Groin complications related to the femoral arterial access
site used for various invasive cardiovascular procedures
represent a significant problem. Among these, femoral
artery pseudoaneurysm (FAP) is one of the most trouble-
some. In the last years, the magnitude of the problem has
been growing with the exponential growth of interventional
cardiology. The FAP occurs in 0.1% to 0.2% of diagnostic
angiograms and 3.5% to 5.5% after interventional proce-
dures (1–6). The incidence of the FAP has increased
recently with the more frequent use of high doses of
antiplatelet and anticoagulant therapy and the use of larger-
sized cannulas for various interventional procedures. For
large persistent pseudoaneurysms, ultrasound-guided com-
pression repair (UGCR) is currently the first line of treat-
ment in order to facilitate the clotting process within the
aneurysm (7,8). However, this method has disadvantages
and limitations. Moreover, its success is limited, and the
recurrence rate is still 20% for patients who are receiving
anticoagulants and antiplatelet therapy (9–11). Finally,
surgical repair is indispensable, but this is often associated
with the need for general anesthesia, with an increased
length of hospital stay and with higher costs.
Several recent attempts have shown that minimal invasive
management may be a reasonable alternative to achieve
pseudoaneurysm thrombosis.
In the 1980s, we introduced the treatment with collagen
insertion. We have developed a nonsurgical, minimally
invasive method to close the FAP percutaneously with
collagen. It has been our approach to use biodegradable
adhesive bovine collagen to facilitate clotting within the
false aneurysm and, thus, achieve the closure. The aim of
this study was to evaluate the efficacy and safety of this
method in a large consecutive group of patients with a FAP.
METHODS
Subjects. The study was conducted between 1993 to 2000.
A total of 110 patients were candidates for treatment with
percutaneous collagen injection at the St. Antonius Hospital
at Nieuwegein. All had recently undergone catheterization
procedures in our institution or in referring centers. All
patients had initially been treated by UGCR, prolonged
compression and bed rest, without success. The procedure
was explained to the patients, and all patients signed an
informed consent form.
These patients underwent ultrasound examination with
duplex scanning along with pulsed and color Doppler flow
mapping (Sonos 2000, Hewlett Packard, Amsterdam, the
Netherlands) employing 7.5 MHz linear array transducer.
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The persistence of the FAP was defined as the presence of
a hypoechogenic cavity with blood flow from the artery into
the FAP in systole and inversely in diastole, visible by
Doppler color flow imaging and pulsed ultrasound. Also,
the size of the FAP was measured (Fig. 1).
Purified bovine collagen has been used in surgical proce-
dures as an adjunct to hemostasis when control of bleeding
by ligature or other conventional methods remains ineffec-
tive. When collagen comes in contact with blood, platelets
aggregate on the collagen and release coagulation factors
that, together with plasma factors, result in the formation of
a fibrin matrix. Once implanted into tissues of an organism,
collagen is ultimately degraded and progressively resorbed
by granulocytes and macrophages. VasoSeal (Datascope
Corp., Montvale, New Jersey) was introduced initially as a
vascular hemostasis device to seal femoral arterial puncture
sites after cardiac catheterization and coronary angioplasty.
It consists of a collagen plug which, when inserted adjacent
to the arterial wall at the puncture site, induces the forma-
tion of a hemostatic cap directly over the arterial puncture
(11). For patients with a FAP, these collagen plugs were
inserted into the pseudoaneurysm to promote clotting in the
FAP.
After our initial experience with collagen plugs, a biode-
gradable adhesive bovine collagen paste (Collagen, Data-
scope Corp., Montvale, New Jersey) was used to promote
hemostasis and accelerate the clotting process within the
pseudoaneurysm.
Contraindications to this procedure included suspected
underlying infection and known allergy to collagen or beef
products.
Procedure. Initially, the collagen was applied guided by
selective angiography using the contralateral access site with
a 4F sheath. After puncture of the contralateral femoral
artery, the 4F catheter is introduced through the sheath and
positioned across the iliac bifurcation in the affected prox-
imal common femoral artery over a guidewire. The injection
of iodine-containing contrast medium allows one to locate
the FAP exactly and correctly, together with its tract and
connections.
After applying routine local anesthesia with 1% ligno-
caine, the pseudoaneurysm cavity is then directly punctured,
leading to high-pressure backflow of blood ensuring correct
access to the pseudoaneurysm. The initial application of the
Vasoseal (collagen plugs) required a larger 11F sheath. After
puncture of the pseudoaneurysm, a guidewire was intro-
duced through the needle to the pseudoaneurysm. The
needle is then removed, leaving the guidewire in place. A
sheath-dilatator is passed over the guidewire into the
pseudoaneurysm cavity, and the guidewire and the dilatator
are removed, leaving only the sheath through which Vaso-
Seal plug could be inserted (Fig. 2). The application of the
collagen paste allows use of a thinner needle. The pseudo-
aneurysm cavity is directly punctured percutaneously using a
9F needle. Then the collagen paste is applied directly through
this 9F needle into the center of the FAP. This produces a
very rapid filling and thrombosis of the pseudoaneurysm.
After 1 to 2 min, a repeat angiogram is performed through
Abbreviations and Acronyms
CI  confidence interval
FAP  femoral artery pseudoaneurysm
UGCR  ultrasound-guided compression repair
Figure 1. Color Doppler ultrasound shows a femoral pseudoaneurysm (F2), its neck (F1) with flow from the femoral artery (A).
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the 4F sheath of the opposite access, to confirm aneurysm
occlusion (Fig. 3).
The patients were observed for any adverse effects, and
the status of the distal pulses were examined before and after
the procedure. Patients underwent a 24-h follow-up clinical
and duplex scanning examination (Fig. 4). This included
duplex assessment of the pseudoaneurysm and physical
examination of the patient.
The primary end points of this study were initial and
six-month success rates and complications.
Data analysis. The hospital records of these patients were
reviewed for the following information: age, gender, type of
procedure, the time interval (in days) between arterial
puncture and collagen injection. The lesion type and the
localization (common, superficial or profunda femoral ar-
tery) were noted.
Figure 2. (A) Angiogram via contralateral site of a pseudoaneurysm of the right femoral artery profunda. (B) After insertion of a thin guidewire, an 11F
catheter is introduced in the pseudoaneurysm. The collagen is applied through this catheter. (C) Final result after collagen injection, the aneurysm is
completely obliterated.
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Figure 3. Angiogram of the right femoral artery via the contralateral site. (A) Bilobulated pseudoaneurysm with its neck arising from the superficial femoral
artery. (B) The pseudoaneurysm is completely visualized. (C) Direct injection of collagen through a needle. (D) Final angiographic control, via the
contralateral site, after obliteration of the pseudoaneurysm.
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Statistical analysis. Only descriptive statistics were used.
The 95% confidence intervals (CIs) for rates were calculated
with the exact binomial method.
RESULTS
There were 55 male and 55 female patients, with a mean age
of 65.6 years (range: 32 to 85 years). Data about the delay
between removal of the femoral catheter to the collagen
injection were available in 106 cases (96%). Delay ranged
from 0 to 96 days (mean 11  12.8 days). There were 110
femoral pseudoaneurysms of which four were associated
with an arteriovenous fistula (5%). Of the 110 pseudoaneu-
rysms, 100 (90.6%) were uniloculated and 10 (9.4%) were
multiloculated. The lesions were caused by diagnostic car-
diac catheterization in 51%, by interventional procedures in
42.8% (29.6% after percutaneous transluminal balloon cor-
onary angioplasty, 13.2% after placement of a stent) and by
other cardiac procedures in 6%. The clinical baseline data of
the patients are shown in Table 1.
In the vast majority of cases, arterial access had been
through the right femoral artery. The location of the injury
was the superficial femoral artery in 41.5% of pseudoaneu-
rysms, the bifurcation of the common femoral artery in
56.9% of cases and the profunda femoral artery in 3.1% of
cases. Data relating to the pseudoaneurysm site are shown in
Table 2.
In the 110 patients, percutaneous collagen injection was
attempted. No patient required either analgesia or sedation.
There were no allergic reactions. In one patient the proce-
dure was aborted because of unfavorable anatomy of the
pseudoaneurysm, and he underwent operative repair.
Therefore, this procedure was technically possible in 109 of
the 110 patients (99.1%). Of the 109 patients who under-
went collagen injection, 107 of 109 (98.1%) had initial
successful obliteration of the pseudoaneurysm regardless of
the anticoagulation status of the patient. Immediate throm-
bosis occurred usually within a few seconds after collagen
application. The mean volume of collagen required for
obliteration of the pseudoaneurysms depends on the volume
of the FAP. Initially, 4 to 12 collagen plugs had to be
inserted. Each plug contained 90 mg collagen. Thereafter,
mean volume of 3 to 9 ml of collagen paste (10 mg
collagen/ml) was injected into the cavity of the pseudoan-
eurysm.
One patient had partial obliteration of the pseudoaneu-
rysm and needed a second successful session of collagen
injection. Closure of the pseudoaneurysm was confirmed by
Figure 4. Color Doppler ultrasound image obtained after collagen injection shows complete thrombosis of the pseudoaneurysm.
Table 1. Clinical Baseline Data
Gender
Male 55 (50%)
Female 55 (50%)
Catheterization
Diagnostic 51%
Angioplasty 30%
Stent placement 12%
Other 7%
Table 2. Lesion Characteristics
Lesions
Pseudoaneurysms 95%
Pseudoaneurysms and arteriovenous fistulas 5%
Lesions locations
Common femoral artery (mostly bifurcation) 56%
Superficial femoral artery 41%
Profunda femoral artery 3%
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the cardiac catheterization laboratory with a second angio-
gram via the contralateral artery.
There was one failure; too much collagen paste was
injected, with protrusion to the vessel without peripheral
migration, which required surgical intervention. Otherwise,
we observed no major complications. In particular, no
peripheral embolic events were documented. No patients
have developed another iatrogenic injury at the contralateral
puncture site. No other adverse effects or local groin
complications were observed.
Immediate procedural success with complete closure of
the pseudoaneurysm was achieved by collagen injection in
107 of 109 cases (97.3%, 95% CI: 92.2% to 99.4%). With
one case of delayed success, the overall success rate was
98.2% (108 of 109 patients, 95% CI: 93.5% to 99.8%)
(Table 3).
Unless other clinical signs prevented discharge, all pa-
tients were discharged from hospital the following day once
repeat duplex scanning had confirmed the absence of any
arterial flow within the earlier cavity. At outpatient clinical
follow-up after six months, no groin problems related to the
collagen injection or recurrences of FAP were noted.
DISCUSSION
Treatment modalities. Iatrogenic FAP in patients who
underwent a diagnostic or therapeutic percutaneous catheter
intervention is not an uncommon complication. Usually,
FAPs are caused by punctures of the femoral artery, which
are too distal, that is, the bifurcation of the femoral artery or
below. Several therapeutic strategies, such as UGCR, sur-
gical repair and minimally invasive percutaneous treatments
(thrombin injection, coil embolization and insertion of
covered stents) have been developed to treat this complica-
tion.
In the last decade, UCGR has become the treatment of
choice (Fellmeth et al. 1991) (7,8). The introduction of this
method has significantly reduced the need for surgical repair
of FAP. Nevertheless, several restrictions for application of
this method, such as long procedure times, discomfort of
patients, relatively high recurrence rate in patients receiving
anticoagulant therapy should be taken into consideration
(7–10,12–16). Furthermore, UGCR requires the availability
of an ultrasound device and the presence of skilled personnel
during the procedure.
Since the first description of an attempt to close a FAP by
percutaneous thrombin injection in the FAP by Cope and
Zeit (17) and subsequently Walker et al. (18) in 1986 and
1987, several publications inspired by this simplified tech-
nique have followed (19–23).
The first attempts to close a FAP with ultrasound-guided
thrombin injections were not without complications. Two
cases of distal migration of the thrombin have been de-
scribed (24,25). These adverse events raise the question:
were these complications due to the nature of the injected
thrombin or was it caused by the way it is used? We believe
that, because thrombin is used in liquid form, it can easily
diffuse from the cavity through the neck of the FAP toward
the lumen of the artery or leave the cavity through an
arteriovenous fistula. It is also possible that if the thrombin
is injected in a too diluted concentration, it does not remain
in the cavity of the FAP long enough to form a clot.
Furthermore, it has been described that patients receiving
thrombin are at risk for developing anti-factor V antibodies,
which may expose them to an immunologic cross-reaction
to human factor V (26,27).
One of the other treatments that have been described for
closure of FAP is the placement of a covered stent in the
femoral artery. This appears not to be an ideal solution for
FAPs that are located near the femoral bifurcation or the
femoral artery itself. This precludes subsequent access of the
femoral artery by the Judkins technique, which is not a
desired situation in patients with coronary artery disease
who may need percutaneous interventions in the future.
Besides that, in 12% to 17% of patients, stent occlusion
occurs within one year (28,29).
Collagen injection. We started to use collagen for the
treatment of FAP in 1993. The initial results proved to be
encouraging because the treatment was safe, efficacious and
without complications. Eventually, this method was devel-
oped in our department as an alternative choice for either
primary treatment of this iatrogenic pathology or treatment
in the majority of cases where UGCR was unsuccessful.
Only in 1 of 110 (0.9%) patients, in whom a collagen
closure attempt was not undertaken, this method appeared
to be not feasible due to an unfavorable anatomy of the
FAP. This results in an overall feasibility of 99.1%. In
contrast to the aforementioned materials that have been
used for percutaneous treatment of FAP, none of the 109
patients treated with collagen showed a local or systemic
adverse reaction. Obliteration of the FAP cavity was
achieved in 107 of 109 patients with a single collagen
injection; in 1 patient an additional injection was required;
this results in an initial success rate of 97.3% and a final
success rate of 98.2%. These results rank collagen injection
among the most successful minimally invasive percutaneous
FAP closure techniques.
Injection of collagen is easily accepted by the patients,
and during the procedure there was no need for systemic
analgesic medication. Complete obliteration was usually
achieved within some 10 s, which is comparable to throm-
bin closure. Whether or not the patient is receiving antico-
agulant therapy does not appear to impair the results.
Table 3. Success Rates of Collagen Injection
95% CI
Initial
Success 107/110 (97.3%) 92.2–99.4
Failure 2/110 (1.8%) 0.2–6.4
Final
Success 108/110 (98.2%) 93.5–99.8
Failure 2/110 (1.8%) 0.2–6.4
CI  confidence interval.
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One therapy failure was noted. In this case, the failure
was caused by the excessive amount of collagen that was to
be injected. Surgical exploration of the groin showed that
the FAP cavity was well obliterated, but collagen that was
present around the FAP caused a compression of the vessel,
without migration of the collagen into the arterial lumen.
No other complications were noted.
The advantages of collagen lie in its physical-chemical
properties. The fact that it consists of long paste fibers
allows the collagen to remain within the FAP cavity, which
putatively reduces the risk of migration through the neck of
the FAP or through a fistula.
Due to its procedural simplicity, ultrasound-guided in-
jection of thrombin remains an appealing treatment. We
have performed the injection of collagen under fluoroscopic
guiding because this made better angiographic visualization
possible, but as with thrombin injection, ultrasound-guided
injection of collagen is certainly feasible. The first FAP
closures in our hospital were realized with the aid of a
collagen plug, which was initially developed for closure of
arterial puncture sites. However, insertion of collagen plugs
in FAPs requires the use of large introducer sheaths (11F).
Subsequently, the development of a paste-like application
form of collagen permitted us to use smaller introducer
sheaths (9F). At present, our research efforts are directed at
developing a sponge-like application form of collagen.
Then, small quantities of sponge-like collagen would suffice
to obliterate the FAP cavity, the percutaneous injection of
which could be monitored by ultrasound.
During 24-h follow-up, clinical inspection of the groin
and lower extremities and ultrasound imaging did not reveal
any recurrences or complications.
Our encouraging preliminary results need further verifi-
cation and confirmation by a prospective trial comparing
collagen closure with other forms of minimally invasive
percutaneous closure of FAP. This will help to establish
success rates, clinical efficacy and cost-effectiveness of the
respective procedures.
Limitations of collagen injection. Utilizing puncture of
the contralateral femoral artery to establish vascular access as
was done in this study appears to make the procedure more
complex. The reason for this approach was to achieve
optimal sterility. In fact, we thought it initially to be difficult
to guarantee procedural sterility if collagen injection is
performed under ultrasound guidance. In the latter case, the
sterile work space is narrow because of the presence of an
ultrasound transducer and gel. Another limitation may be
because this study was performed in a single center.
Conclusions. In view of our experience with direct injec-
tion of collagen, we are convinced that this technique is safe
and efficacious, and these results suggest that this method
may be used not only after failure of traditional closure
techniques, but also as primary treatment of FAP. Collagen
injection is a fast, expeditious method permitting early
mobilization and discharge.
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